Glaxo Smithkline Consumer Heathcare Ltd
⚠️ Moderate Risk
FEI: 3004181768 • Gurgaon, Haryana • INDIA
FEI Number
3004181768
Location
Gurgaon, Haryana
Country
INDIAAddress
Plaza Tower, , Gurgaon, Haryana, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
HEALTH C
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.
INCONSPICU
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/9/2015 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Seattle District Office (SEA-DO) | |
| 11/9/2015 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Seattle District Office (SEA-DO) | |
| 11/9/2015 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Seattle District Office (SEA-DO) | |
| 11/9/2015 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Seattle District Office (SEA-DO) | |
| 11/9/2015 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | Seattle District Office (SEA-DO) | |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 9/15/2014 | 30YGT99BEVERAGE BASE NOT MENTIONED ELSEWHERE, N.E.C. | 75UNAPPROVED | Los Angeles District Office (LOS-DO) |
| 3/8/2011 | 30GGT99BEVERAGE BASE OF NON-FRUIT ORIGIN, LIQUID, N.E.C. | Seattle District Office (SEA-DO) | |
| 3/8/2011 | 30GGT99BEVERAGE BASE OF NON-FRUIT ORIGIN, LIQUID, N.E.C. | Seattle District Office (SEA-DO) | |
| 5/12/2009 | 09CHT08MILK, MALTED | Southwest Import District Office (SWI-DO) | |
| 10/17/2006 | 31EFY99COFFEE SUBSTITUTES, N.E.C. | Seattle District Office (SEA-DO) |
Frequently Asked Questions
What is Glaxo Smithkline Consumer Heathcare Ltd's FDA import refusal history?
Glaxo Smithkline Consumer Heathcare Ltd (FEI: 3004181768) has 15 FDA import refusal record(s) in our database, spanning from 10/17/2006 to 11/9/2015.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Smithkline Consumer Heathcare Ltd's FEI number is 3004181768.
What types of violations has Glaxo Smithkline Consumer Heathcare Ltd received?
Glaxo Smithkline Consumer Heathcare Ltd has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Glaxo Smithkline Consumer Heathcare Ltd come from?
All FDA import refusal data for Glaxo Smithkline Consumer Heathcare Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.